General aspects of surgical treatment of pancreatic cancer

Digestive Surgery

Volumn 16, Issue 4, 1999, Pages 265-275

  Pedrazzoli, Sergio ^a   Pasquali, Claudio ^b   Sperti, Cosimo ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

Lymphadenectomy; Pancreatic cancer; Portal vein resection

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; METASTASIS; MORBIDITY; PANCREAS CANCER; PORTAL VEIN; RADIODIAGNOSIS; REVIEW; SURGICAL TECHNIQUE; VEIN SURGERY;

HUMANS; LYMPH NODE EXCISION; NEOPLASM RECURRENCE, LOCAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PORTAL VEIN; SURVIVAL RATE;

EID: 0032764302     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018735     Document Type: Article

References (80)

1. Pasquali C, Sperti C, Filipponi C, Pedrazzoli S: Epidemiology of pancreatic cancer in northcast Italy. Study on incidence (1990-92), hospital stay and survival, 30th EPC Meeting, Thessaloniki, 1998. Digestion 1998;59:213.
2. SEER Cancer Statistics Review, 1973-1995, National Cancer Institute (preliminary edition). http.//www.seer.ims.nci.nih.gov/Publications/CSR7395/.
3. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 1998; 48:6-29.
4. Crile G: The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970;130:1049-1053.
5. Hertzberg J: Pancreatico-duodenal resection and by-pass operation in patients with carcinoma of the head of the pancreas, ampulla, and distal end of the common duct. Acta Chir Scand 1974;140:523-527.
6. Shapiro TM: Adenocarcinoma of the pancreas: A statistical analysis of bypass vs. Whipple resection in good risk patients. Ann Surg 1975; 182:715-721.
7. Lieberman MD, Kiburn H, Lindsey M, Brennan MF: Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 1995;222:638-645.
8. Glasgow RE, Mulvihill SJ: Hospital volume influences outcome in patients undergoing pancreatic resection for cancer. West J Med 1996;165:294-300.
9. Neoptolemos JP, Russell RCG, Bramhall S, Theis B: Low mortality following resection for pancreatic and periampullary tumours in 1026 patients, UK survey of specialist pancreatic units. Br J Surg 1997;84:1370-1376.
10. Trede M, Schwall G, Saeger H-D: Survival after pancreatoduodenectomy. 118 consecutive resections without operative mortality. Ann Surg 1990;211:447-458.
11. Geer RJ, Brennan MF: Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68-73.
12. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J: One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217: 430-438.
13. Lillemoe KD, Cameron JL, Yeo CJ, et al: Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg 1996;223:718-728.
14. Kausch W: Das Carcinom der Papilla duodeni und seine radikale Entfernung. Beitr Klin Chir 1912;78:439.
15. Whipple AO, Parsons WB, Mullins CR: Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935;102:763-779.
16. Nakase A, Matsumoto Y, Uchida K, Honjo I: Surgical treatment of cancer of the pancreas and the periampullary region: Cumulative results in 57 institutions in Japan. Ann Surg 1977;185:52-57.
17. Johnson CD, Schwall G, Flechtenmacher J, Trede M: Resection for adenocarcinoma of the body and tail of the pancreas. Br J Surg 1993; 80:1177-1179.
18. Traverso LW, Longmire WP: Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 1978;146:959-962.
19. Di Carlo V, Zerbi C, Balzano G: Surgical treatment: Whipple-Kausch pancreatoduodenectomy with or without pylorus preservation: in Beger HG, Warshaw AL, Büchler MW, Carr-Loeke DL, Neoptolemos J, Russell C, Sarr MG (eds): The Pancreas. Oxford, Blackwell Science, 1998, vol 2, pp 1028-1040.
20. Van Heerden JA, ReMine WH, Weiland LH, McIlrath DC, Ilstrup DM: Total pancreatectomy for ductal adenocarcinoma of the pancreas: Mayo Clinic experience. Am J Surg 1981;142: 308-311.
21. Moossa AR, Scott MH, Lavelle-Jones M: The place of total and extended total pancreatectomy in pancreatic cancer. World J Surg 1984;8: 895-899.
22. Brooks JR, Brooks DC, Levine JD: Total pancreatectomy for ductal cell carcinoma of the pancreas: an update. Ann Surg 1989;209:405-410.
23. Fortner JG: Regional resection of cancer of the pancreas: A new surgical approach. Surgery 1973;73:307-320.
24. Cubilla AL, Fortner J, Fitzgerald PJ: Lymph node involvement in carcinoma of the pancreas area. Cancer 1978;41:880-887.
25. Ishikawa O, Ohhigashi H, Sasaki Y, et al: Practical usefulness of lymphatic and connective tissue clearance for carcinoma of the pancreas head. Ann Surg 1988;208:215-220.
26. Manabe T, Ohshio G, Baba N, et al: Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 1989;64: 1132-1137.
27. Ihse I, Anderson H, Andrén-Sandberg Å: Total pancreatectomy for cancer of the pancreas: Is it appropriate? World J Surg 1996;20:288-294.
28. Fortner JG, Klimstra DS, Senie RT, Maclean BJ: Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg 1996;223:147-153.
29. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA: Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:721-733.
30. Sindelar WE: Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989;124:127-132.
31. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman J: Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120-124.
32. Launois B, Franci J, Bardaxoglu E, Ramee MP Paul JL, Malledant Y, Campion JP: Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer. World J Surg 1993;17:122-127.
33. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S: Survival after resection for ductal adcnocarcinoma of the pancreas. Br J Surg 1996;83:625-631.
34. Andersen HB, Baden H, Bille Brahe NE, Burcharth F: Pancreaticoduocenectomy for periampullary adenocarcinoma. J Am Coll Surg 1994;179:545-552.
35. Tsao JI, Rossi RL, Lowell JA: Pylorus preserving pancreatoduodenectomy. Is it an adequate cancer operation? Arch Surg 1994;129:405-412.
36. Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, de Wit Th, Verbeck PCM, Gouma DJ: Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg 1994;81: 1642-1646.
37. Fernandez-del Castillo C, Rattner DW, Warshaw AL: Standards for pancreatic resection in the 1990s. Arch Surg 1995;130:295-300.
38. Harrison LE, Kimstra DS, Brennan MF: Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg 1996;224:342-349.
39. Mosca F, Giulianotti PC, Balestracci T, Di Candio G, Pietrabissa A, Sbrana F, Rossi G: Long-term survival in pancreatic cancer: Pylorus-preserving versus whipple pancreatoduodenectomy. Surgery 1997;122:553-566.
40. Leach SD, Lee JE, Charnsangavey C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PWT, Evans DB: Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 1998;85:611-617.
41. Fortner JG: Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Ann Surg 1984;199:418-425.
42. Tashiro S, Uchino R, Hiraoka T, Tsuji T, Kawamoto S, Saitoh N, Yamasaki K, Miyauchi Y: Surgical indication and significance of portal vein resection in biliary and pancreatic cancer. Surgery 1991;109:481-487.
43. Gotoh M, Monden M, Sakon M, Kanai T, Umeshita K, Ikeda H, Mori T: Intraoperative irradiation in resected carcinoma of the pancreas and portal vein. Arch Surg 1992;127: 1213-1215.
44. Ishikawa O, Ohigashi H, Imaoka S, Furukawa H, Sasaki Y, Fujita M, Kuroda C, Iwanaga T: Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992;215: 231-236.
45. Nakao A, Harada A, Nonami T, Kaneko T, Takagi H: Regional vascular resection using catheter bypass procedure for pancreatic cancer. Hepatogastroenterology 1995;42:734-739.
46. Takahashi S, Ogata Y, Miyazaki H, Maeda D, Murai S, Yamataka K, Tsuzuki T: Aggressive surgery. World J Surg 1995;19:653-660.
47. Nagakawa T, Nagamori M, Futakami F, Tsukioka Y, Kayahara M, Ohta T, Ueno K, Miyazaki I: Results of extensive surgery for pancreatic carcinoma. Cancer 1996;77:640-645.
48. Ishikawa O: Surgical technique, curability and postoperative quality of life in an extended pancreatectomy for carcinoma of the head of the pancreas. Hepatogastroenterology 1996;43: 320-325.
49. Imaizumi T, Hanyu F, Harada N, Hatori T, Fukuda A: Extended radical whipple resection for cancer of the pancreatic head: operative procedure and results. Dig Surg 1998;15:299-307.
50. Naganuma T, Isaji S, Kawarada Y: Staging and extended resection for pancreatic cancer. Pancreas 1998;16:355-362.
51. Ishikawa O, Ohigashi H, Sasaki Y, Nakano H, Furukawa H, Imaoka S, Takenaka A, Kasugai T, Ishiguro S: Intraoperative cytodiagnosis for detecting a minute invasion of the portal vein during pancreatoduodenectomy for adenocarcinoma of the pancreatic head. Am J Surg 1998;175:477-481.
52. Nagai H, Kuroda A, Morioka Y: Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material. Ann Surg 1986;204:65-71.
53. Nagakawa T, Kayahara M, Ohta T, et al: Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer. Int J Pancreatol 1991;10:113-119.
54. Kayahara M, Nagakawa T, Ueno K. et al: Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion. Surgery 1995;117:616-623.
55. Hiraoka T, Uchino R, Kanemitsu K, Toyonaga M, Saitoh N, Nakamura I, Tashiro S, Miyauchi Y: Combination of intraoperative radiation with resection of cancer of the pancreas. Int J Pancreatol 1990;7:201-207.
56. Gall FP, Kessler H, Hermanek P: Surgical treatment of ductal pancreatic carcinoma. Eur J Surg Oncol 1991;17:173-181.
57. Nagakawa T, Konishi I, Ueno K, Ohta T, Akiyama T, Kayahara M, Miyazaki I: Surgical treatment of pancreatic cancer. The Japanese experience. Int J Pancreatol 1991;9:135-143.
58. Satake K, Nishiwaki H, Yokomatsu H, et al: Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 1992;175: 259-265.
59. Henne-Bruns D, Kremer B, Meyer-Pennwitt U, et al: Partial duodenopancreatectomy with radical lymphadenectomy in patients with pancreatic and periampullary carcinomas: Initial results. Hepatogastroenterology 1993;40:145-149.
60. Hirata K, Sato T, Mukaya M, Yomashiro K, Kimura M, Sasaki K, Denno R: Results of 1001 pancreatic resections for invasive ductal adenocarcinoma of the pancreas. Arch Surg 1997;132:771-776.
61. Iacono C, Bortolasi L, Facci E, et al: Does extended pancreaticoduodenectomy increase operative morbility and mortality vs. standard pancreatoduodenectomy? J Gastrointest Surg 1997;1:446-453.
62. Pedrazzoli S, Di Carlo V, Dionigi R, et al: Traditional versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. A multicentric, prospective, randomized study. Ann Surg 1998;228: 508-517.
63. Mukaiya M, Hirata K, Satoh T, et al: Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: Retrospective multi-institutional analysis in Japan. World J Surg 1998;22: 248-253.
64. Hanyu M, Imaizumi T, Harada N: Extended radical surgery for carcinoma of the head of the pancreas; in Beger HG, Warshaw AL, Büchler MW, Carr-Locke DL, Neoptolemos J, Russell C, Sarr MG (eds): The Pancreas. Oxford, Blackwell Science, 1998, vol 2, pp 1041-1046.
65. Hiraoka T, Kanemitsu K: Combined treatment of resection with intraoperative radiotherapy; in Beger HG, Warshaw AL, Büchler MW, Carr-Locke DL, Neoptolemos J, Russell C, Sarr MG (eds): The Pancreas. Oxford, Blackwell Science, 1998, vol 2, pp 1085-1091.
66. Solassol C, Joyeux H, Yakoun M, Blanc F, Bories P: La pancréatectomie régionale dans le traitement de l'adénocarcinome du pancréas. A propos de 41 cas. Gastroenterol Clin Biol 1984; 8:17-21.
67. Henne Bruns D, Vogel I, Lüttges J, Klöppel G, Kremer B: Ductal adenocarcinoma of the pancreas head: Survival after regional versus extended lymphadenectomy. Hepatogastroenterology 1998;45:855-866.
68. Masson B, Loze S, Bercovici D: La lymphadénectomie élargie dans la chirurgie de l'adénocarcinome pancréatique est-elle justifiée? A propos d'une série de 59 cas. Chirurgie 1994-1995;120:216-218.
69. Lee Y-TM, Tatter D: Carcinoma of the pancreas and periampullary structures. Pattern of metastasis at autopsy. Arch Pathol Lab Med 1984;108:584-587.
70. Westerdahl J, Andrén-Sandberg Å: Recurrence of exocrine pancreatic cancer. Local or hapatic? Hepatogastroenterology 1993;40:384-387.
71. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC: Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 1993; 217:144-148.
72. Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB: Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996;171:118-125.
73. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S: Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 1997;21: 195-200.
74. Bluemke DA, Abrams RA, Yeo CJ, Cameron JL, Fishman EK: Recurrent pancreatic adenocarcinoma: Spiral CT evaluation following the Whipple procedure. Radiographics 1997;17: 303-313.
75. Hoffman JP, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB III: Phase II trial of preopcrative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group study. J Clin Oncol 1998;16:317-323.
76. Beretta E, Malesci A, Zerbi A, Mariani A, Carlucci M, Bonato C, Ferrari AM, Di Carlo V: Serum CA 19-9 in the postsurgieal follow-up of patients with pancreatic cancer. Cancer 1987; 60:2428-2431.
77. Sperti C, Pasquali C, Catalini S, Cappellazzo F, Bonadimani B, Behboo R, Pedrazzoli C: CA 19-9 as a prognostic index after resection for pancreatic cancer. J Surg Oncol 1993;52:137-141.
78. Safi F, Schlosser W, Falkenreck S, Beger HG: CA 19-9 serum course and prognosis of pancreatic cancer. Int J Pancreatol 1996;20:155-161.
79. Laundin J, Roberts PJ, Kuusela P, Haglund C: The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. Br J Cancer 1994;69:515-519.
80. Forsmark CE, Lambiase L, Vogel SB: Diagnosis of pancreatic cancer and prediction of unresectability using the tumor-associated antigen CA 19-9. Pancreas 1994;9:731-734.